Top Markets
#1 Codatta Codatta +16.44%
#2 SuperVerse SuperVerse +14.29%
#3 Ski Mask Dog Ski Mask Dog +10.89%
#4 BitMEX BitMEX +9.81%
#5 Qkacoin Qkacoin +9.49%
#6 Yooldo Games Yooldo Games +8.94%
#7 Bedrock Bedrock +8.33%
#8 Audiera Audiera +8.31%
#9 Bless Bless +8.21%
#10 SOSANA SOSANA +8.10%
Coin of the day
Codatta Codatta
Settings
Language
ENGLISH
Currency
USD
Theme
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rank in Stocks #18708
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Share Price
$2.49
Market Cap
$4.47M
Change (1 day)
-4.01%
Change (1 year)
678.16%
Country
MY
Trade BioNexus Gene Lab Corporation (BGLC)

Category

Healthcare
Revenue for BioNexus Gene Lab Corporation (BGLC)
Revenue in Sep 2025 TTM: $9.47M
According to BioNexus Gene Lab Corporation latest financial reports the company's current revenue (TTM) is $9.47M. In 2023 the company made a revenue of $9.77M a decrease compared to the revenue in the year 2022 that was $10.93M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioNexus Gene Lab Corporation from 2016 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $9.47M -0.48%
2024 $9.51M -2.66%
2023 $9.77M -10.60%
2022 $10.93M -18.21%
2021 $13.36M 17.31%
2020 $11.39M 8,872.03%
2019 $126.96K -40.21%
2018 $212.33K 97.18%
2017 $107.68K 0.00%
2016 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $44.56B 470,644.55%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $24.57B 259,466.66%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.30B 45,369.62%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
2359.HK
 $6.23B 65,758.80%
CN
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
 $7.07B 74,543.38%
US